GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 165 filers reported holding GOSSAMER BIO INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $77,683 | +24.5% | 64,736 | +30.7% | 0.00% | – |
Q1 2023 | $62,410 | -50.4% | 49,532 | -13.3% | 0.00% | – |
Q4 2022 | $125,823 | -59.1% | 57,112 | +122.5% | 0.00% | – |
Q3 2022 | $307,551 | +38.6% | 25,672 | -3.1% | 0.00% | – |
Q2 2022 | $221,847 | -5.7% | 26,505 | -2.2% | 0.00% | – |
Q1 2022 | $235,237 | -37.8% | 27,101 | -18.9% | 0.00% | – |
Q4 2021 | $378,000 | -14.1% | 33,426 | -4.6% | 0.00% | – |
Q3 2021 | $440,000 | +41.5% | 35,030 | -8.5% | 0.00% | – |
Q2 2021 | $311,000 | -4.9% | 38,294 | +8.3% | 0.00% | – |
Q1 2021 | $327,000 | -4.4% | 35,370 | +0.0% | 0.00% | – |
Q4 2020 | $342,000 | -14.7% | 35,360 | +9.3% | 0.00% | – |
Q3 2020 | $401,000 | +5.0% | 32,337 | +6.8% | 0.00% | – |
Q2 2020 | $382,000 | +32.2% | 30,282 | +6.5% | 0.00% | – |
Q1 2020 | $289,000 | -30.4% | 28,442 | +7.2% | 0.00% | – |
Q4 2019 | $415,000 | -9.2% | 26,536 | -0.1% | 0.00% | -100.0% |
Q3 2019 | $457,000 | +65.6% | 26,574 | +113.5% | 0.00% | – |
Q2 2019 | $276,000 | – | 12,449 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |